Atorvastatin and Micronized Fenofibrate Alone and in Combination in Type 2 Diabetes With Combined Hyperlipidemia

Diabetes Care - United States
doi 10.2337/diacare.25.7.1198
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Incidence of Type 2 Diabetes in Familial Combined Hyperlipidemia

BMJ Open Diabetes Research and Care
EndocrinologyMetabolismDiabetes
2020English

Canagliflozin: Efficacy and Safety in Combination With Metformin Alone or With Other Antihyperglycemic Agents in Type 2 Diabetes

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Effectiveness of Coelatura Aegyptiaca Extract Combination With Atorvastatin on Experimentally Induced Hyperlipidemia in Rats

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2019English

Comparison of Teneligliptin and Atorvastatin on Lipid Profile in Patients With Type 2 Diabetes Mellitus

Current Research in Diabetes & Obesity Journal
2018English

SGLT2 Inhibitor Ipragliflozin Alone and Combined With Pioglitazone Prevents Progression of Nonalcoholic Steatohepatitis in a Type 2 Diabetes Rodent Model

Physiological Reports
Physiology
2019English

Treatment Options for Type 2 Diabetes in Adolescents and Youth: A Study of the Comparative Efficacy of Metformin Alone or in Combination With Rosiglitazone or Lifestyle Intervention in Adolescents With Type 2 Diabetes

Pediatric Diabetes
Internal MedicinePediatricsEndocrinologyPerinatologyChild HealthMetabolismDiabetes
2007English

Erratum To: Favourable Effects of Fenofibrate on Lipids and Cardiovascular Disease in Women With Type 2 Diabetes: Results From the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Effects of Fenofibrate in Patients With Type 2 Diabetes Mellitus Complicated by Diabetic Neuropathy

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Paradoxical Decrease in HDL-cholesterol and Apolipoprotein A1 With Simvastatin and Atorvastatin in a Patient With Type 2 Diabetes

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy